By Adriano Marchese
Titan Medical Inc. said it will cut costs and furlough staff to preserve its funds while it undergoes a review of its strategic options.
The Canadian medical robotics technology said Tuesday that it will furlough about 40 employees at its Chapel Hill, N.C., facility, which is part of its U.S. subsidiary, effective immediately.
In late November, the company launched a review process to evaluate a range of strategic alternatives, including a corporate sale, a merger or other business combination, a sale of all or a portion of the company's assets, and a strategic investment or other significant transaction.
Titan Medical said the furloughs are necessary for it to continue working on its investigation device exemption filing with the U.S. Food and Drug Administration and to support the strategic alternatives review process.
Cost-cutting measures will affect the timing and costs of the company's milestones, including the development of its Enos surgical system, Titan Medical said.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
December 06, 2022 09:42 ET (14:42 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。